Antibody response to the 23-valent pneumococcal polysaccharide vaccine after conjugate vaccine in patients with chronic lymphocytic leukemia

The 23-valent pneumococcal polysaccharide vaccine (PPV23) given alone is ineffective in patients with chronic lymphocytic leukemia (CLL) and better antibody response is achieved with pneumococcal conjugate vaccines (PCVs). In this study, we determine whether CLL patients would achieve a significant...

Full description

Saved in:
Bibliographic Details
Published in:Hum Vaccin Immunother
Main Authors: Lindström, Vesa, Aittoniemi, Janne, Salmenniemi, Urpu, Käyhty, Helena, Huhtala, Heini, Sinisalo, Marjatta
Format: Artigo
Language:Inglês
Published: Taylor & Francis 2019
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6930110/
https://ncbi.nlm.nih.gov/pubmed/31216225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1627160
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items